-
Something wrong with this record ?
Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results
Z. Starek, A. Di Cori, TR. Betts, G. Clerici, D. Gras, E. Lyan, P. Della Bella, J. Li, B. Hack, L. Zitella Verbick, P. Sommer
Language English Country England, Great Britain
Document type Journal Article
Grant support
Abbott
NLK
Free Medical Journals
from 1999 to 1 year ago
PubMed Central
from 2008
Open Access Digital Library
from 1999-01-01
Medline Complete (EBSCOhost)
from 1999-01-01
Oxford Journals Open Access Collection
from 1999-01-01
- MeSH
- Time Factors MeSH
- Electrophysiologic Techniques, Cardiac MeSH
- Atrial Fibrillation * diagnosis surgery MeSH
- Atrial Flutter * diagnosis surgery etiology MeSH
- Catheter Ablation * adverse effects methods MeSH
- Humans MeSH
- Recurrence MeSH
- Heart Rate MeSH
- Heart Atria MeSH
- Pulmonary Veins * surgery MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
AIMS: Electro-anatomical mapping may be critical to identify atrial fibrillation (AF) subjects who require substrate modification beyond pulmonary vein isolation (PVI). The objective was to determine correlations between pre-ablation mapping characteristics and 12-month outcomes after a single PVI-only catheter ablation of AF. METHODS AND RESULTS: This study enrolled paroxysmal AF (PAF), early persistent AF (PsAF; 7 days-3 months), and non-early PsAF (>3-12 months) subjects undergoing de novo PVI-only radiofrequency catheter ablation. Sinus rhythm (SR) and AF voltage maps were created with the Advisor HD GridTM Mapping Catheter, Sensor EnabledTM for each subject, and the presence of low-voltage area (LVA) (low-voltage cutoffs: 0.1-1.5 mV) was investigated. Follow-up visits were at 3, 6, and 12 months, with a 24-h Holter monitor at 12 months. A Cox proportional hazards model identified associations between mapping data and 12-month recurrence after a single PVI procedure. The study enrolled 300 subjects (113 PAF, 86 early PsAF, and 101 non-early PsAF) at 18 centres. At 12 months, 75.5% of subjects were free from AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence. Univariate analysis found that arrhythmia recurrence did not correlate with AF diagnosis, but LVA was significantly correlated. Low-voltage area (<0.5 mV) >28% of the left atrium in SR [hazard ratio (HR): 4.82, 95% confidence interval (CI): 2.08-11.18; P = 0.0003] and >72% in AF (HR: 5.66, 95% CI: 2.34-13.69; P = 0.0001) was associated with a higher risk of AF/AFL/AT recurrence at 12 months. CONCLUSION: Larger extension of LVA was associated with an increased risk of arrhythmia recurrence. These subjects may benefit from substrate modification beyond PVI.
Arrhythmia Unit and Electrophysiology Laboratories Ospedale San Raffaele Milano Italy
Department for Electrophysiology Herz und Diabetes Zentrum NRW Bad Oeynhausen Germany
Department of Cardiology Hopital Prive du Confluent Nantes France
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016624
- 003
- CZ-PrNML
- 005
- 20231026105653.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/europace/euad194 $2 doi
- 035 __
- $a (PubMed)37470443
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Starek, Zdenek $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 664/53, Brno 60200, Czech Republic $u First Department of Internal Medicine/Cardioangiology, St. Anne's Hospital, Masaryk University, Pekarska 664/53, Brno 60200, Czech Republic $1 https://orcid.org/0000000295101386
- 245 10
- $a Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results / $c Z. Starek, A. Di Cori, TR. Betts, G. Clerici, D. Gras, E. Lyan, P. Della Bella, J. Li, B. Hack, L. Zitella Verbick, P. Sommer
- 520 9_
- $a AIMS: Electro-anatomical mapping may be critical to identify atrial fibrillation (AF) subjects who require substrate modification beyond pulmonary vein isolation (PVI). The objective was to determine correlations between pre-ablation mapping characteristics and 12-month outcomes after a single PVI-only catheter ablation of AF. METHODS AND RESULTS: This study enrolled paroxysmal AF (PAF), early persistent AF (PsAF; 7 days-3 months), and non-early PsAF (>3-12 months) subjects undergoing de novo PVI-only radiofrequency catheter ablation. Sinus rhythm (SR) and AF voltage maps were created with the Advisor HD GridTM Mapping Catheter, Sensor EnabledTM for each subject, and the presence of low-voltage area (LVA) (low-voltage cutoffs: 0.1-1.5 mV) was investigated. Follow-up visits were at 3, 6, and 12 months, with a 24-h Holter monitor at 12 months. A Cox proportional hazards model identified associations between mapping data and 12-month recurrence after a single PVI procedure. The study enrolled 300 subjects (113 PAF, 86 early PsAF, and 101 non-early PsAF) at 18 centres. At 12 months, 75.5% of subjects were free from AF/atrial flutter (AFL)/atrial tachycardia (AT) recurrence. Univariate analysis found that arrhythmia recurrence did not correlate with AF diagnosis, but LVA was significantly correlated. Low-voltage area (<0.5 mV) >28% of the left atrium in SR [hazard ratio (HR): 4.82, 95% confidence interval (CI): 2.08-11.18; P = 0.0003] and >72% in AF (HR: 5.66, 95% CI: 2.34-13.69; P = 0.0001) was associated with a higher risk of AF/AFL/AT recurrence at 12 months. CONCLUSION: Larger extension of LVA was associated with an increased risk of arrhythmia recurrence. These subjects may benefit from substrate modification beyond PVI.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a fibrilace síní $x diagnóza $x chirurgie $7 D001281
- 650 12
- $a venae pulmonales $x chirurgie $7 D011667
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a elektrofyziologické techniky kardiologické $7 D022062
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a srdeční síně $7 D006325
- 650 12
- $a flutter síní $x diagnóza $x chirurgie $x etiologie $7 D001282
- 650 12
- $a katetrizační ablace $x škodlivé účinky $x metody $7 D017115
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Di Cori, Andrea $u Second Division of Cardiovascular Diseases, Cardiac-Thoracic and Vascular Department, New Santa Chiara Hospital, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy $1 https://orcid.org/0000000230837376
- 700 1_
- $a Betts, Timothy R $u Department of Cardiology, John Radcliffe Hospital, Oxford, UK $1 https://orcid.org/0000000190639905
- 700 1_
- $a Clerici, Gael $u Cardiology Department, Rhythmology Unit, Centre Hospitalier Universitaire de La Reunion, La Reunion, France $1 https://orcid.org/0000000246316196
- 700 1_
- $a Gras, Daniel $u Department of Cardiology, Hopital Prive du Confluent, Nantes, France $1 https://orcid.org/0000000279806036
- 700 1_
- $a Lyan, Evgeny $u Department of Cardiology, Section of Electrophysiology, Herz-und Gefäßzentrum Bad Bevensen, Bad Bevensen, Germany $1 https://orcid.org/0000000196969227
- 700 1_
- $a Della Bella, Paolo $u Arrhythmia Unit and Electrophysiology Laboratories, Ospedale San Raffaele, Milano, Italy $1 https://orcid.org/0000000183461387
- 700 1_
- $a Li, Jingyun $u Abbott, Saint Paul, MN, USA
- 700 1_
- $a Hack, Benjamin $u Abbott, Saint Paul, MN, USA
- 700 1_
- $a Zitella Verbick, Laura $u Abbott, Saint Paul, MN, USA $1 https://orcid.org/0000000313599916
- 700 1_
- $a Sommer, Philipp $u Department for Electrophysiology, Herz-und Diabetes Zentrum NRW, Bad Oeynhausen, Germany $1 https://orcid.org/0000000230378704
- 773 0_
- $w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 25, č. 9 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37470443 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105648 $b ABA008
- 999 __
- $a ok $b bmc $g 2000254 $s 1202986
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 25 $c 9 $e 2023Aug02 $i 1532-2092 $m Europace $n Europace $x MED00149837
- GRA __
- $p Abbott
- LZP __
- $a Pubmed-20231013